Showing results (81-90 of 108) with videos related to
Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|June 14, 2021
Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapiesSydney Ch'ng, Semra Uyulmaz, Matteo S Carlino, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 16, 2025
Longitudinal Analysis Reveals Dynamic Changes in Histopathologic Features in Responders to Neoadjuvant Treatment in a Stage III BRAF-Mutant Melanoma CohortJorja Braden, Alison Potter, Robert V Rawson, et al.Australian Journal of General Practice|May 29, 2020
Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma managementCaroline G Watts, Andrea L Smith, Sam Robinson, et al.The Lancet. Oncology|June 8, 2019
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trialGeorgina V Long, Robyn P M Saw, Serigne Lo, et al.Human Molecular Genetics|July 28, 2020
Multiplex melanoma families are enriched for polygenic riskMatthew H Law, Lauren G Aoude, David L Duffy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2024
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA CalculatorAlexander H R Varey, Isabel Li, Mary-Ann El Sharouni, et al.Annals of Surgical Oncology|November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional ImagingCaroline A Gjorup, Rachel Woodford, Isabel Li, et al.JAMA Surgery|February 9, 2022
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III MelanomaIrene L M Reijers, Robert V Rawson, Andrew J Colebatch, et al.NPJ Breast Cancer|October 29, 2025
A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trialsShelley Potter, Kerry Avery, Rosina Ahmed, et al.International Journal of Cancer|September 5, 2018
Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibilityJames S Wilmott, Peter A Johansson, Felicity Newell, et al.Pageof 11